Probiotics and prebiotics in ulcerative colitis

Ananthakrishnan, 2015, Epidemiology and risk factors for IBD, Nat Rev Gastroenterol Hepatol, 12, 205, 10.1038/nrgastro.2015.34

Frei, 2013, Use of thiopurines in inflammatory bowel disease, World J Gastroenterol WJG, 19, 1040, 10.3748/wjg.v19.i7.1040

Andersson, 2009, Surgery in ulcerative colitis: indication and timing, Dig Dis, 27, 335, 10.1159/000228570

Sartor, 2006, Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis, Nat Clin Pract Gastroenterol Hepatol, 3, 390, 10.1038/ncpgasthep0528

Campieri, 1999, Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?, Gastroenterol, 116, 1246, 10.1016/S0016-5085(99)70029-6

Swidsinski, 2002, Mucosal flora in inflammatory bowel disease, Gastroenterology, 122, 44, 10.1053/gast.2002.30294

D'Haens, 1998, Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum, Gastroenterology, 114, 262, 10.1016/S0016-5085(98)70476-7

Janowitz, 1998, The role of the fecal stream in Crohn's disease: an historical and analytic review, Inflamm Bowel Dis, 4, 29, 10.1097/00054725-199802000-00006

Rutgeerts, 1991, Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum, Lancet, 338, 771, 10.1016/0140-6736(91)90663-A

Wellmann, 1986, Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid, Gut, 27, 814, 10.1136/gut.27.7.814

Khan, 2011, Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis, Am J Gastroenterol, 106, 661, 10.1038/ajg.2011.72

Jostins, 2012, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature, 491, 119, 10.1038/nature11582

Moayyedi, 2015, Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial, Gastroenterology, 149, 10.1053/j.gastro.2015.04.001

Jandhyala, 2015, Role of the normal gut microbiota, World J Gastroenterol WJG, 21, 8787, 10.3748/wjg.v21.i29.8787

Eckburg, 2005, Diversity of the human intestinal microbial flora, Science, 308, 1635, 10.1126/science.1110591

Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci U S A, 104, 13780, 10.1073/pnas.0706625104

Takaishi, 2008, Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease, Int J Med Microbiol IJMM, 298, 463, 10.1016/j.ijmm.2007.07.016

Jonkers, 2012, Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients, Drugs, 72, 803, 10.2165/11632710-000000000-00000

Arumugam, 2011, Enterotypes of the human gut microbiome, Nature, 473, 174, 10.1038/nature09944

Ghouri, 2014, Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease, Clin Exp Gastroenterol, 7, 473

Sartor, 2008, Microbial influences in inflammatory bowel diseases, Gastroenterology, 134, 577, 10.1053/j.gastro.2007.11.059

Mallon, 2007, Probiotics for induction of remission in ulcerative colitis, Cochrane Database Syst Rev, CD005573

Orel, 2014, Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease, World J Gastroenterol WJG, 20, 11505, 10.3748/wjg.v20.i33.11505

Bellavia, 2013, Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis, Med Microbiol Immunol, 202, 393, 10.1007/s00430-013-0305-2

Nagasaki, 2010, Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium, Digestion, 81, 204, 10.1159/000236042

Chibbar, 2015, Probiotics in the management of ulcerative colitis, J Clin Gastroenterol, 49, S50, 10.1097/MCG.0000000000000368

Matthes, 2010, Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN), BMC Complement Altern Med, 10, 13, 10.1186/1472-6882-10-13

Rembacken, 1999, Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial, Lancet, 354, 635, 10.1016/S0140-6736(98)06343-0

Petersen, 2014, Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial, J Crohn's Colitis, 8, 1498, 10.1016/j.crohns.2014.06.001

Huynh, 2009, Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study, Inflamm Bowel Dis, 15, 760, 10.1002/ibd.20816

Sood, 2009, The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, 7

Bibiloni, 2005, VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis, Am J Gastroenterol, 100, 1539, 10.1111/j.1572-0241.2005.41794.x

Miele, 2009, Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis, Am J Gastroenterol, 104, 437, 10.1038/ajg.2008.118

Ng, 2010, Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis, Inflamm Bowel Dis, 16, 1286, 10.1002/ibd.21222

Soo, 2008, VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation, Can J Gastroenterol J Can de Gastroenterol, 22, 237, 10.1155/2008/520383

Tursi, 2004, Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis, Med Sci Monit Int Med J Exp Clin Res, 10, PI126

Tursi, 2010, Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study, Am J Gastroenterol, 105, 2218, 10.1038/ajg.2010.218

Mardini, 2014, Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis, Inflamm Bowel Dis, 20, 1562, 10.1097/MIB.0000000000000084

Hegazy, 2010, Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis, World J Gastroenterol WJG, 16, 4145, 10.3748/wjg.v16.i33.4145

Li, 2012, The effect of bifid triple viable on immune function of patients with ulcerative colitis, Gastroenterol Res Pract, 2012, 404752, 10.1155/2012/404752

Furrie, 2005, Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial, Gut, 54, 242, 10.1136/gut.2004.044834

Kato, 2004, Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis, Alimentary Pharmacol Ther, 20, 1133, 10.1111/j.1365-2036.2004.02268.x

Zigra, 2007, Probiotics and remission of ulcerative colitis: a systematic review, Neth J Med, 65, 411

Guslandi, 2010, Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis, J Clin Gastroenterol, 44, 385, 10.1097/MCG.0b013e3181cb4233

Kruis, 2004, Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine, Gut, 53, 1617, 10.1136/gut.2003.037747

Kruis, 1997, Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis, Alimentary Pharmacol Ther, 11, 853, 10.1046/j.1365-2036.1997.00225.x

Waljee, 2014, Point-counterpoint: are we overtreating patients with mild ulcerative colitis?, J Crohn's Colitis, 8, 80, 10.1016/j.crohns.2013.07.003

Venturi, 1999, Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis, Alimentary Pharmacol Ther, 13, 1103, 10.1046/j.1365-2036.1999.00560.x

Zocco, 2006, Efficacy of lactobacillus GG in maintaining remission of ulcerative colitis, Alimentary Pharmacol Ther, 23, 1567, 10.1111/j.1365-2036.2006.02927.x

Ishikawa, 2011, Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study, Digestion, 84, 128, 10.1159/000322977

Naidoo, 2011, Probiotics for maintenance of remission in ulcerative colitis, Cochrane Database Syst Rev, CD007443

Bouhnik, 2004, The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study, Am J Clin Nutr, 80, 1658, 10.1093/ajcn/80.6.1658

Ballongue, 1997, Effects of lactulose and lactitol on colonic microflora and enzymatic activity, Scand J Gastroenterol Suppl, 222, 41, 10.1080/00365521.1997.11720716

Bindels, 2015, Towards a more comprehensive concept for prebiotics, Nat Rev Gastroenterol Hepatol, 12, 303, 10.1038/nrgastro.2015.47

Fernandez-Banares, 1999, Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU), Am J Gastroenterol, 94, 427, 10.1111/j.1572-0241.1999.872_a.x

Casellas, 2007, Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin, Alimentary Pharmacol Ther, 25, 1061, 10.1111/j.1365-2036.2007.03288.x

Fujimori, 2009, A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis, Nutrition, 25, 520, 10.1016/j.nut.2008.11.017

Floch, 2015, Recommendations for probiotic Use-2015 update: proceedings and consensus opinion, J Clin Gastroenterol, 49, S69, 10.1097/MCG.0000000000000420

Guslandi, 2003, A pilot trial of Saccharomyces boulardii in ulcerative colitis, Eur J Gastroenterol Hepatol, 15, 697, 10.1097/00042737-200306000-00017

Tsuda, 2007, Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy, Scand J Gastroenterol, 42, 1306, 10.1080/00365520701396091

Takeda, 2009, Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis, Inflamm Bowel Dis, 15, 1617, 10.1002/ibd.20861

D'Inca, 2011, Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis, Dig Dis Sci, 56, 1178, 10.1007/s10620-010-1384-1

Oliva, 2012, Randomised clinical trial: the effectiveness of lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis, Alimentary Pharmacol Ther, 35, 327, 10.1111/j.1365-2036.2011.04939.x

Ishikawa, 2003, Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis, J Am Coll Nutr, 22, 56, 10.1080/07315724.2003.10719276

Cui, 2004, Effects of probiotic on intestinal mucosa of patients with ulcerative colitis, World J Gastroenterol WJG, 10, 1521, 10.3748/wjg.v10.i10.1521

Wildt, 2011, A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis, J Crohn's Colitis, 5, 115, 10.1016/j.crohns.2010.11.004

Kanauchi, 2003, Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial, Int J Mol Med, 12, 701

Hafer, 2007, Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study, BMC Gastroenterol, 7, 36, 10.1186/1471-230X-7-36

Hallert, 1991, Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission, Scand J Gastroenterol, 26, 747, 10.3109/00365529108998594

Hanai, 2004, Germinated barley foodstuff prolongs remission in patients with ulcerative colitis, Int J Mol Med, 13, 643